Show simple item record

dc.contributor.authorTejada-Pérez, Juan José
dc.contributor.authorVázquez-Vicente, Juan José
dc.contributor.authorHerrera-Burgos, María Renée
dc.contributor.authorMartín-Martín, Francisco Gabriel
dc.contributor.authorParrón-Carreño, Tesifón
dc.contributor.authorAlarcón-Rodríguez, Raquel
dc.date.accessioned2021-04-12T08:05:07Z
dc.date.available2021-04-12T08:05:07Z
dc.date.issued2021-03-19
dc.identifier.issn2076-393X
dc.identifier.urihttp://hdl.handle.net/10835/10484
dc.description.abstractHepatitis B (HBV) is a pathogen virus with transmission mechanisms that include contact with the infected blood or bodily fluids of the infected organism. Nowadays, healthcare workers are one of the most exposed groups to HBV. Conventionally, completing a vaccine series dosage with Engerix B® lowers this risk by providing workers with immunity to the virus. However, through the years, we have encountered nonresponsive health personnel to the Engerix B® vaccine; hence, the Occupational Health Service of Poniente Hospital studied the Fendrix® adjuvanted vaccine as an alternative vaccine to develop immunological responses in healthcare workers who do not respond to vaccination with Engerix B®. In our study, we employed a vaccination schedule with the Fendrix® vaccine, performing serology tests on the cases after the application of each dose. The results obtained showed humoral immunity in 92.3% of the cases, with a remarkable increase in antibody titer after the first doses. These encouraging results support the future inclusion of this vaccine as one possible alternative for the immunization to HBV for healthcare workers nonresponsive to Engerix B®es_ES
dc.language.isoenes_ES
dc.publisherMDPIes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectHepatitis Bes_ES
dc.subjectvaccinationes_ES
dc.subjectfendrixes_ES
dc.subjecthealthcare workerses_ES
dc.subjectoccupational healthes_ES
dc.titleFendrix® Vaccine Effectiveness in Healthcare Workers Who Are Non-Responsive to Engerix B® Vaccinationes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttps://www.mdpi.com/2076-393X/9/3/279es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional